|
|
Volumn 12, Issue 3, 2000, Pages 323-340
|
|
Opportunistic fungal infections in the critically ill.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIFUNGAL AGENT;
ASPERGILLOSIS;
BIOAVAILABILITY;
CANDIDIASIS;
CRITICAL ILLNESS;
CROSS INFECTION;
DRUG COST;
ECONOMICS;
HUMAN;
INFECTION CONTROL;
INTENSIVE CARE;
INTENSIVE CARE UNIT;
METHODOLOGY;
MYCOSIS;
NURSING ASSESSMENT;
OPPORTUNISTIC INFECTION;
PATIENT SELECTION;
REVIEW;
RISK FACTOR;
ANTIFUNGAL AGENTS;
ASPERGILLOSIS;
BIOLOGICAL AVAILABILITY;
CANDIDIASIS;
CRITICAL CARE;
CRITICAL ILLNESS;
CROSS INFECTION;
DRUG COSTS;
HUMANS;
INFECTION CONTROL;
INTENSIVE CARE UNITS;
MYCOSES;
NURSING ASSESSMENT;
OPPORTUNISTIC INFECTIONS;
PATIENT SELECTION;
RISK FACTORS;
MLCS;
MLOWN;
|
|
EID: 0034285851
PISSN: 08995885
EISSN: None
Source Type: Journal
DOI: 10.1016/s0899-5885(18)30098-4 Document Type: Review |
|
Times cited : (5)
|
|
References (92)
|
